IMMIXBIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Mar 2026)
What this means for you
This application is over — abandoned 23 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90813912
- Mark type
- Stylized text
- Filed
- 06 Jul 2021
- Published for opposition
- 27 Dec 2022
- Abandoned
- 23 Mar 2026
- Attorney of record
- Sheila R. Gibson
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents
Owner
- Immix Biopharma, Inc., Los Angeles, CA, US
- Immix Biopharma, Inc., Los Angeles, CA, US
Prosecution history
- 23 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 5 GRANTED
- 20 Aug 2025 — SOU EXTENSION 5 FILED
- 07 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2025 — SOU EXTENSION 4 GRANTED
- 20 Feb 2025 — SOU EXTENSION 4 FILED
- 19 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2024 — SOU EXTENSION 3 GRANTED
- 25 Jul 2024 — SOU EXTENSION 3 FILED
- 25 Jul 2024 — SOU TEAS EXTENSION RECEIVED